Arcturus Therapeutics Holdings Inc. (ARCT)

CIK 0001768224 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-06) · 99.1
Q1-2026 8-K (2026-05-07) · 99.1
Latest FY-2025 8-K (2026-03-03) · 99.1
Q3-2025 8-K (2025-11-10) · 99.1
Q2-2025 8-K (2025-08-11) · 99.1
Q1-2025 8-K (2025-05-12) · 99.1
FY-2024 8-K (2025-03-06) · 99.1
Q3-2024 8-K (2024-11-07) · 99.1
Q2-2024 8-K (2024-08-05) · 99.1
Q1-2024 8-K (2024-05-08) · 99.1
FY-2023 8-K (2024-03-07) · 99.1
Q3-2023 8-K (2023-11-14) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Operations and Comprehensive (loss) Income
—
Consolidated Statements of Operations and Comprehensive Income (loss)
—
Condensed Consolidated Statements of Stockholders' Equity
—
Consolidated Statements of Changes In Stockholders' Equity
—
Consolidated Statements of Cash Flows
Notes
Accrued Liabilities Detail
—
Balance Sheet Details
—
Commitments and Contingencies
Cybersecurity Risk Management, Strategy, and Governance
—
Debt
Description of Business, Basis of Presentation and Summary of Significant Accounting Policies
—
Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Organization
—
Other Balance Sheet Details
—
Pay Vs Performance Disclosure
Property and Equipment, Net
—
Related Party Transactions
Revenue
Segment Information
Share-based Compensation
—
Share-based Compensation Expense
—
Stockholders' Equity
Subsequent Events
Summary of Significant Accounting Policies
—